Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: A modelling study

Journal article published in Human Vaccines & Immunotherapeutics and co-authored by PATH's Frédéric Debellut, Clint Pecenka, and Bill Hausdorff.

Publication date: November 2022

Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: A modelling study

View Resource